Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection
Laurent Vallat
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorYves Benhamou
Department of Hepatogastroenterology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorMaya Gutierrez
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorPascale Ghillani
Department of Immunochemistry, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorChristel Hercher
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorVincent Thibault
Department of Virology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorFrédéric Charlotte
Department of Pathology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorJean-Charles Piette
Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorThierry Poynard
Department of Hepatogastroenterology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorHélène Merle-Béral
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorFrédéric Davi
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorCorresponding Author
Patrice Cacoub
Hôpital La Pitié-Salpêtrière, Paris, France
Department of Internal Medicine, Hôpital La Pitié-Salpêtrière, 83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, FranceSearch for more papers by this authorLaurent Vallat
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorYves Benhamou
Department of Hepatogastroenterology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorMaya Gutierrez
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorPascale Ghillani
Department of Immunochemistry, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorChristel Hercher
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorVincent Thibault
Department of Virology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorFrédéric Charlotte
Department of Pathology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorJean-Charles Piette
Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorThierry Poynard
Department of Hepatogastroenterology, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorHélène Merle-Béral
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorFrédéric Davi
Department of Hematology, Assistance Publique Hopitaux, Hôpital La Pitié-Salpêtrière, Paris, France
Search for more papers by this authorCorresponding Author
Patrice Cacoub
Hôpital La Pitié-Salpêtrière, Paris, France
Department of Internal Medicine, Hôpital La Pitié-Salpêtrière, 83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, FranceSearch for more papers by this authorAbstract
Objective
The association of hepatitis C virus (HCV) infection with type II mixed cryoglobulinemia is well established, but the role of HCV in B cell lymphoma remains controversial. The objective of this study was to determine the frequency of circulating and liver-infiltrating monoclonal B cells in patients with HCV infection.
Methods
One hundred sixty patients were studied prospectively, including 115 HCV-positive patients and 45 HCV-negative patients with other nonimmune chronic liver disease(s). B cell clonality was determined by DNA amplification of the IgH rearrangements, followed by polyacrylamide gel electrophoresis.
Results
A clonal B cell population was detected in the blood of 21 (26%) of 81 HCV-positive patients whose cryoglobulin status was known, including 12 of 25 patients with type II cryoglobulinemia, 2 of 12 patients with type III cryoglobulinemia, and 7 of 44 patients without cryoglobulins. A clonal IgH rearrangement was detected in 26 (32%) of 81 liver biopsy specimens from HCV- infected patients, including 16 patients with a circulating clonal population. A clonal B cell population was not observed in the blood of 40 patients with non-HCV liver diseases and was present in only 1 (3%) of 30 liver biopsy specimens. Logistic regression analysis showed that HCV-infected patients with clonal B cell proliferation in both the blood and liver were older (P = 0.004) and had longer duration of HCV infection (P = 0.009), higher serum cryoglobulin levels (P = 0.001) that were more frequently symptomatic (P < 0.03), and liver disease that was more severe than that in patients without a clonal B cell population in the blood or liver (P = 0.05). In 4 of 16 patients with a clonal B cell population in both the blood and liver, a definite B cell malignancy was finally diagnosed.
Conclusion
Clonal B lymphocytes are frequently detected in the blood and liver of patients with chronic HCV infection, in the absence of overt B cell malignancy. These clones are usually, but not always, associated with the presence of type II cryoglobulins. A high percentage of patients with B cell clonality in both the blood and liver were finally diagnosed as having a definite B cell malignancy.
REFERENCES
- 1 Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991; 88: 2451–5.
- 2 Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225–9.
- 3 Zinkernagel RM, Hengartner H. Antiviral immunity. Immunol Today 1997; 18: 258–60.
- 4 Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999; 30: 595–601.
- 5 Colombo M. The role of hepatitis C virus in hepatocellular carcinoma. Recent Results Cancer Res 1998; 154: 337–44.
- 6 Brechot C. Molecular mechanisms of hepatitis B and C viruses related to liver carcinogenesis. Hepatogastroenterology 1998; 45 Suppl 3: 1189–96.
- 7 Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938–41.
- 8 Muratori L, Gibellini D, Lenzi M, Cataleta M, Muratori P, Morelli MC, et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996; 88: 2768–74.
- 9 Boisvert J, He XS, Cheung R, Keeffe EB, Wright T, Greenberg HB. Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 2001; 184: 827–35.
- 10 Lunel F, Musset L. Hepatitis C virus infection and cryoglobulinemia. J Hepatol 1998; 29: 848–55.
- 11 Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994; 96: 124–32.
- 12 Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al, for the MULTIVIRC group. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42: 2204–12.
- 13 Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-α and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis. Arthritis Rheum 2002; 46: 3317–26.
- 14 Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490–5.
- 15 Santini GF, Giannini F, Crovatto M, Ceselli S, Mazzaro C, Donada C, et al. HCV and lymphoproliferative diseases. Clin Exp Rheumatol 1995; 13 Suppl 13: S51–7.
- 16 Santini GF, Crovatto M, Giannini F, Bortolin MT, Mazzaro C, Invernizzi F. Hepatitis C virus and immunoglobulin gene rearrangements: an early step in lymphomagenesis? Acta Haematol 1998; 100: 117–22.
- 17 Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995; 90: 548–52.
- 18 Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, et al. Bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001; 112: 364–9.
- 19
Magalini AR,
Facchetti F,
Salvi L,
Fontana L,
Puoti M,
Scarpa A.
Clonality of B cells in portal lymphoid infiltrates of HCV-infected livers.
J Pathol
1998;
185:
86–90.
10.1002/(SICI)1096-9896(199805)185:1<86::AID-PATH59>3.0.CO;2-R CAS PubMed Web of Science® Google Scholar
- 20 Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160: 3594–601.
- 21 Monteverde A, Ballare M, Bertoncelli MC, Zigrossi P, Sabattini E, Poggi S, et al. Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 1995; 13 Suppl 13: S141–7.
- 22 Racanelli V, Sansonno D, Piccoli C, D'Amore FP, Tucci FA, Dammacco F. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001; 167: 21–9.
- 23 Galli-Stampino L, Pasqualini A, Pozzato G, Bonino F, Filipponi F, Mosca M, et al. Molecular analysis of V(H)I+ B lymphocytes in hepatitis C patients. Dig Liver Dis 2003; 35: 788–94.
- 24 Silvestri F, Baccarani M. Hepatitis C virus-related lymphomas. Br J Haematol 1997; 99: 475–80.
- 25 Perez Sanchez I, Rivera Redondo J, Garcia Monforte A, Mayoayo Crespo M, Escudero Soto A, Pintado Cros T. B-lymphoproliferative disorders in patients with hepatitis C virus infection. Haematologica 1998; 83: 946–8.
- 26 Shirin H, Davidovitz Y, Avni Y, Petchenko P, Krepel Z, Bruck R, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc J 2002; 4: 24–7.
- 27 Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001; 16: 215–9.
- 28 Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423–8.
- 29 Brind AM, Watson JP, Burt A, Kestevan P, Wallis J, Proctor SJ, et al. Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk Lymphoma 1996; 21: 127–30.
- 30 McColl MD, Singer IO, Tait RC, McNeil IR, Cumming RL, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma: a regional association? Leuk Lymphoma 1997; 26: 127–30.
- 31 Singer IO, Cumming RL, Hogg RB. Is hepatitis C associated with non-Hodgkin's lymphoma? Leuk Lymphoma 1997; 26: 633–4.
- 32 Thalen DJ, Raemaekers J, Galama J, Cooreman MP. Absence of hepatitis C virus infection in non-Hodgkin's lymphoma. Br J Haematol 1997; 96: 880–1.
- 33 Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prummer O, Klatt S, et al. HCV and HGV in B-cell non-Hodgkin's lymphoma. J Hepatol 1998; 28: 34–9.
- 34 King PD, Wilkes JD, Diaz-Arias AA. Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin Lab Haematol 1998; 20: 107–10.
- 35 Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, et al. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240–2.
- 36 Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D, et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999; 93: 1778–9.
- 37 Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001; 67: 168–71.
- 38
Hausfater P,
Cacoub P,
Rosenthal E,
Bernard N,
Loustaud-Ratti V,
Le Lostec Z, et al, and the
GERMIVIC Group.
Hepatitis C virus infection and lymphoproliferative diseases in France: a national study.
Am J Hematol
2000;
64:
107–11.
10.1002/(SICI)1096-8652(200006)64:2<107::AID-AJH6>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 39 Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38: 798–802.
- 40 Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775–88.
- 41 Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287–308.
- 42 Aubin J, Davi F, Nguyen-Salomon F, Leboeuf D, Debert C, Taher M, et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 1995; 9: 471–9.
- 43 Davi F, Faili A, Gritti C, Blanc C, Laurent C, Sutton L, et al. Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells. Blood 1997; 90: 4014–21.
- 44 Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20(1 Pt 1): 15–20.
- 45 Bedossa P, Poynard T, and the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289–93.
- 46 Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002; 100: 2289–90.
- 47 Bichard P, Ounanian A, Girard M, Baccard C, Rolachon A, Renversez JC, et al. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. J Hepatol 1994; 21: 58–63.
- 48 Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon-α in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81: 1132–6.
- 49 Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansions. Blood 1998; 9: 1864–72.
- 50 De Vita S, De Re V, Gasparotto D, Ballarè M, Pivetta B, Ferraccioli G, et al. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. Arthritis Rheum 2000; 43: 94–102.
- 51 Kyle RA, Therneau TM, Rajkumar SV, Offard JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564–9.
- 52 Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97–104.
- 53 Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Sandreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89–94.
